Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
AUPH
AUPH
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
AUPH News
Biotech Landscape Update: Regulatory Approvals and Acquisitions
Apr 03 2026
NASDAQ.COM
Aurinia Acquires Kezar Life Sciences for $6.955 per Share
Mar 30 2026
seekingalpha
Aurinia Pharmaceuticals to Acquire Kezar Life Sciences in $6.955 Per Share Deal
Mar 30 2026
NASDAQ.COM
AURINIA PHARMACEUTICALS TO PURCHASE KEZAR LIFE SCIENCES FOR $6.955 PER SHARE IN CASH, ALONG WITH A CONTINGENT VALUE RIGHT
Mar 30 2026
moomoo
Aurinia Appoints New CEO and CFO Amid Shareholder Concerns
Mar 23 2026
stocktwits
Aurinia Appoints New CEO to Enhance Shareholder Value
Mar 23 2026
Newsfilter
Aurinia Pharmaceuticals Appoints New CEO and Executives
Mar 23 2026
seekingalpha
Overview of 13D Filings
Mar 14 2026
Yahoo Finance
Aurinia and Vornado Executives Make Significant Stock Purchases
Mar 04 2026
NASDAQ.COM
Aurinia Pharmaceuticals Q4 Earnings Beat Expectations
Feb 26 2026
Benzinga
Aurinia Pharmaceuticals Reports Strong Q4 2025 Earnings and 2026 Outlook
Feb 26 2026
seekingalpha
Aurinia Pharmaceuticals Q4 Earnings Beat Expectations
Feb 26 2026
stocktwits
Aurinia Pharmaceuticals Q4 Earnings Beat Expectations
Feb 26 2026
seekingalpha
Aurinia Pharma to Announce Q4 Earnings on February 26
Feb 25 2026
seekingalpha
Aurinia Pharmaceuticals to Report Financial Results on February 26, 2026
Feb 19 2026
Newsfilter
Reasons to Consider Aurinia Pharmaceuticals (AUPH) as a Strong Momentum Stock: Is It Time to Buy?
Dec 05 2025
NASDAQ.COM
Show More News
